MIR.V
Price:
$0.135
Market Cap:
$98.43M
MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, the Asia Pacific, and internationally. The company offers Reveal HIV that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests, including combination testing solutions for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product to perform preliminary screening of HIV and hepatitis. It also provides Miriad RVF toolkit that facilitates the development...[Read more]
Industry
Biotechnology
IPO Date
1999-12-01
Stock Exchange
TSXV
Ticker
MIR.V
According to MedMira Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 106.92M. This represents a change of 55.33% compared to the average of 68.83M of the last 4 quarters.
The mean historical Enterprise Value of MedMira Inc. over the last ten years is 74.75M. The current 106.92M Enterprise Value has changed 14.20% with respect to the historical average. Over the past ten years (40 quarters), MIR.V's Enterprise Value was at its highest in in the January 2021 quarter at 235.55M. The Enterprise Value was at its lowest in in the July 2016 quarter at 6.20M.
Average
74.75M
Median
52.28M
Minimum
15.10M
Maximum
288.02M
Discovering the peaks and valleys of MedMira Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.81%
Maximum Annual Enterprise Value = 288.02M
Minimum Annual Increase = -67.77%
Minimum Annual Enterprise Value = 15.10M
Year | Enterprise Value | Change |
---|---|---|
2024 | 73.95M | 2.67% |
2023 | 72.03M | -25.55% |
2022 | 96.75M | 4.21% |
2021 | 92.84M | -67.77% |
2020 | 288.02M | 1.81% |
2019 | 15.10M | -27.21% |
2018 | 20.75M | -21.80% |
2017 | 26.53M | -18.45% |
2016 | 32.54M | 12.09% |
2015 | 29.03M | -21.38% |
The current Enterprise Value of MedMira Inc. (MIR.V) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
80.91M
5-year avg
124.72M
10-year avg
74.75M
MedMira Inc.’s Enterprise Value is
Company | Enterprise Value | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MedMira Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MedMira Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is MedMira Inc.'s Enterprise Value?
What is the highest Enterprise Value for MedMira Inc. (MIR.V)?
What is the 3-year average Enterprise Value for MedMira Inc. (MIR.V)?
What is the 5-year average Enterprise Value for MedMira Inc. (MIR.V)?
How does the current Enterprise Value for MedMira Inc. (MIR.V) compare to its historical average?